Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia · Delayed Price · Currency is AUD 2.100
+0.010 (0.48%)
Sep 17, 2026, 4:10 PM AEST
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 779.74 million as of September 16, 2026. Its market cap has decreased by -39.23% in one year.
Market Cap
779.74M
Enterprise Value
601.49M
Revenue
10.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.10
ChartMarket Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 779.74M, an increase of 102.95%. That is a compound annual growth rate of 15.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 779.74M | -37.99% |
| Dec 31, 2025 | 1.26B | -6.00% |
| Dec 31, 2024 | 1.34B | 168.49% |
| Dec 29, 2023 | 498.26M | 93.82% |
| Dec 30, 2022 | 257.07M | 35.63% |
| Dec 31, 2021 | 189.54M | -50.67% |
| Aug 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 2.65B |
| Neuren Pharmaceuticals | 2.58B |
| PYC Therapeutics | 2.21B |
| Clinuvel Pharmaceuticals | 409.98M |
| Racura Oncology | 398.02M |
| Starpharma Holdings | 362.40M |
| Tetratherix | 345.41M |
| BLS Pharmaceuticals | 271.76M |